Peptide Synthesis Market Revenue to Cross USD 5.1 billion by 2035

Published: February 2024


According to a recently published report by Roots Analysis, the growing demand for peptide therapeutics and preference for outsourcing of peptide manufacturing is driving the peptide synthesis market growth.

Peptide Synthesis Industry Overview

The global peptide synthesis market is anticipated to grow at a CAGR of 5.5% from 2024-2035, reaching USD 5.1 billion by 2035

The synthetic peptide APIs find various applications in medicine, immunology, and molecular biology. Given the numerous advantages of peptide therapeutics, their demand has increased considerably, resulting in significant growth of peptide synthesis market. The rise in demand for peptide-based therapeutics, coupled with the requirement of complex manufacturing process and substantial capital investments for facility, has prompted the peptide therapeutic developers to increasingly outsource their manufacturing operations to contract manufacturers, which offer several benefits, such as access to large capacity, well-equipped manufacturing facility, scientists and experts of peptide synthesis field.

Browse 160+ figures and 180+ market data tables spread across 390+ pages and detailed Table of Content on “Peptide Synthesis Market by Type of Peptide Synthesis Method, Type of Chemical Synthesis, Contract Manufacturing Organization Size and Key Geographical Regions: Industry Trends and Global Forecasts, Till 2035” here: https://www.rootsanalysis.com/reports/peptide-therapeutics-manufacturing/305.html

Market Drivers

Over the years, the interest of pharmaceutical industry in peptide drugs has increased substantially owing to the various benefits and success of such therapeutics in the treatment of cancer, diabetes, HIV infection, and multiple sclerosis. This has further led to increased investments, and R&D activity in this domain. Additionally, the growing pipeline of peptide therapeutics has led to considerable increase in demand for peptide-based APIs. To overcome the shortage of in-house production capacity, pharmaceutical companies are increasingly seeking support from peptide contract manufacturers to produce peptide-based drug products / substances, which is likely to drive the market forward in the coming years.

Market Restraints

Peptide synthesis and peptide API manufacturing is a complex, multi-step process which requires various chemical synthesis steps and efficient purification methods for eliminating impurities from the final product. Additionally, the lack of cost-effective, scalable and sustainable technologies that are specifically designed for peptide API production, concerns related to good quality and stringent regulatory guidelines pose several challenges for the manufacturers.

Growth Factors

The increase in demand for GLP-1-mediated drugs has primarily resulted in substantial growth of the market. This can be attributed to the fact that GLP-1 medications were fundamentally designed for the treatment of type II diabetes, however, the use of these drugs led to significant weight loss in patients, leading to a surge in their demand. Additionally, rise in the number of clinical trials and regulatory approval of peptide therapeutics in recent years, has drawn various stakeholders to invest largely in research and development of these peptide drugs. Considering the increasing pace of innovation and research activity, the peptide synthesis market is anticipated to witness a steady growth in the foreseen future.

Peptide Synthesis Market Segments

Based on the type of peptide synthesis method, the market is segmented into chemical synthesis method and non-chemical synthesis method.

  • The chemical synthesis method segment is likely to lead the market for peptide synthesis, capturing the largest revenue share close to 85.0% in 2024.
  • The non-chemical synthesis method segment is anticipated to grow at an annualized rate of over 5% during the forecast period.

Based on the chemical synthesis method, the market is segmented into liquid phase synthesis, solid phase synthesis and hybrid phase synthesis.

  • The solid phase synthesis segment is likely to lead the market for peptide synthesis, capturing the largest revenue share of close to 50.0% in 2024.
  • The hybrid phase synthesis segment is anticipated to grow at an annualized rate of over 8% during the forecast period.

Based on the contract manufacturing organization size, the market is segmented into small companies, mid-sized companies, and large and very large companies.

  • The large and very large companies segment is likely to lead the market for peptide synthesis, capturing the largest revenue share of 75.0% in 2024.
  • The market segment for small companies is anticipated to grow at an annualized rate of over 9% during the forecast period.

Based on the regional insights, the market is segmented into North America, Europe, and Asia-Pacific and Rest of the World

  • Europe dominated the peptide synthesis market and is likely to capture the largest revenue share of nearly40.0% in 2024.
  • In Asia-Pacific, the peptide synthesis market is anticipated to demonstrate lucrative growth during the forecast period.

Key Companies Profiled

The peptide synthesis market report also includes detailed profiles of key players (listed below) that offer peptide synthesis services:

  • AmbioPharm
  • CPC Scientific
  • Creative Peptides
  • CSBio
  • Bachem
  • BCN Peptide
  • CordenPharma
  • Senn Chemicals
  • PolyPeptide
  • Auspep
  • Chinese Peptide Company
  • Hybio Pharmaceuticals
  • Peptide Institute
  • ScinoPharm

You Can Download Free Sample PDF Copy of This Report At:
https://www.rootsanalysis.com/reports/peptide-therapeutics-manufacturing/request-sample.html

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact Details

Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com

MEDIA CITATIONS

  • We are your partners with no equity

  • We fit in your budget

  • We love what we do

  • Chance to prove ourselves

  • Best in class quality of work

  • Most trusted consulting partner in the industry